GramEye

GramEye

Private
IbarakiHealthcare & Life Scienceshttps://grameye.com/

Last Round

Series B

Nov 21, 2025

Total Funding Raised

$6.09M

Momentum Score

50 /100

Company Overview

GramEye is a medical technology company that develops an AI and robotics solution to automate Gram staining, aiming to facilitate the appropriate use of antimicrobials.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Biotech Equipment, Workflow Automation

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

automated Gram stainingAI bacterial identificationinfectious disease diagnosticsmedtechantimicrobial resistanceAMRmedical AIdiagnostic AIlab automationmedical devicediagnostic roboticsmicroscopy AIcomputational pathologyclinical workflow automationclinical decision support systemCDSS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GramEye Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

GramEye Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BNov 21, 2025
Series AOct 13, 2023

Key People

Founding team and executive leadership

Yu Hiraoka

CEO

Executive Team

Ryo Matsukage

CTO AI Development Group Manager

Executive Team

Yamada Tatsuya

COO

Executive Team

GramEye Investors

Notable investors and investment history

InvestorRounds
DEEPCORE Inc.Series A
Ikeda Senshu CapitalSeries A
Samurai Incubate Inc.Series A, Series B
NES Inc.Series A, Series B
Beyond Next VenturesSeries B
STATION Ai CorporationSeries A
SMBC Venture CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors increased 55% MoM.

  • Apr 5, 2026

    Monthly visitors increased 86% MoM, reaching 10.2K.

GramEye Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GramEye Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GramEye's valuation, stock price, and market status.

Firmographic Details

HeadquartersIbaraki
Employee Range6
Year Founded2020
Last FundingNov 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.